Company / Current Liabilities
Dynavax Technologies Corp. Current Liabilities History
FY2015-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities
$78.6M
FY2024
5-year range
$62.2M / $556.4M
FY2020-FY2024
Trend
+26.4%
vs FY2023
Sector context
#117 of 215
Health Care
What the data says
At $79M, Dynavax Technologies Corp.'s current liabilities ranks #99 of 215 in the Health Care sector. Current Liabilities returned to growth in FY2024 after 2 years of decline, reaching $79M.
Based on SEC 10-K filings.
$79M in FY2024 with a 5-year CAGR of +8.2%.
Improved from $150M to $79M over the past 2 years.
Health Care sector context is included.
Current Liabilities over time
Growth rates
- 3-Year CAGR
- -47.9%
- 5-Year CAGR
- +8.2%
- 10-Year CAGR
- -
Sector benchmark
#99 of 215 in Health CareTop 46% of 215This company $78.6M Sector average $1.6B
▼
-95.0% below sector average
Key checks
Key Insights
- 5-year CAGR of +8.2%, indicating consistent growth.
- In FY2024, current liabilities increased 26.4% year-over-year.
- Ranks #117 out of 215 companies in the Health Care sector.
- Peak current liabilities was recorded in FY2021.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current LiabilitiesValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $78.6M | +26.4% |
| FY2023 | $62.2M | -58.6% |
| FY2022 | $150.1M | -73.0% |
| FY2021 | $556.4M | +618.8% |
| FY2020 | $77.4M | +45.9% |
| FY2019 | $53.0M | +39.5% |
| FY2018 | $38.0M | +104.6% |
| FY2017 | $18.6M | -7.2% |
| FY2016 | $20.0M | -30.4% |
| FY2015 | $28.8M | +41.9% |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026